What is the management of essential tremor and gastrointestinal inflammation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The management of essential tremor and gastrointestinal inflammation involves a multi-faceted approach, with essential tremor typically treated with medications like propranolol or primidone, and gastrointestinal inflammation treated based on the specific condition, such as inflammatory bowel diseases or gastritis, with medications like aminosalicylates, corticosteroids, or biologics. The treatment of essential tremor often involves beta-blockers, with propranolol being a commonly used medication, as noted in a study published in 2022 1. For gastrointestinal inflammation, the approach depends on the severity and type of inflammation. Some key considerations include:

  • For inflammatory bowel diseases like Crohn's or ulcerative colitis, medications such as aminosalicylates (e.g., mesalamine 2-4 g daily), corticosteroids (e.g., prednisone 40-60 mg daily for acute flares), immunomodulators (e.g., azathioprine 2-3 mg/kg/day), or biologics (e.g., infliximab, adalimumab) may be prescribed, as discussed in a 2020 study 1.
  • For less severe inflammation like gastritis, proton pump inhibitors (e.g., omeprazole 20-40 mg daily) and dietary modifications (avoiding spicy foods, alcohol, and NSAIDs) are recommended.
  • Lifestyle modifications, including stress reduction, adequate sleep, and avoiding caffeine and alcohol, can help manage both conditions, as these substances can exacerbate both tremors and gastrointestinal symptoms. It's also important to consider the potential gastrointestinal side effects of medications used to treat essential tremor, such as beta-blockers, which may cause nausea or diarrhea, as noted in the 2022 study 1. Additionally, a 2019 study 1 highlights the importance of a stepwise approach to rule out ongoing inflammatory activity in patients with inflammatory bowel disease and persistent gastrointestinal symptoms. Overall, a comprehensive approach that addresses both essential tremor and gastrointestinal inflammation, while considering potential interactions and side effects, is crucial for effective management.

From the Research

Management of Essential Tremor

  • The management of essential tremor has two major approaches: excluding treatable etiologies and symptomatic treatment 2
  • First-line pharmacological treatments include propranolol, primidone, and topiramate 2, 3, 4
  • Botulinum toxin injections are effective in some tremor patterns, especially wrist flexion/extension and head tremor 2, 4, 5
  • For severe tremor, surgical lesioning or deep brain stimulation of the thalamus is justified and often dramatically improves function 2, 4
  • Topiramate has been suggested as a potentially useful agent for the treatment of essential tremor, but there is uncertainty about its efficacy and safety 6

Treatment Options

  • Mild to moderate tremor severity can sometimes be controlled with occupational treatment, speech therapy, or adaptation of coping strategy 2
  • Other agents including ethanol, benzodiazepines, gabapentin, levetiracetam, and zonisamide may be effective 4
  • Polypharmacy may be considered in some cases 4
  • Local injections with botulinum toxin A may be useful for patients with refractory essential tremor, especially those with head tremor 5

Future Therapeutic Options

  • T calcium channel blockers, modulators of GABAA receptors, GABAB receptors, and glutamatergic neurotransmission, and drugs that decrease the expression of LINGO-1 could be interesting options for the future 5
  • Further research is needed to assess the efficacy and safety of topiramate and other drugs for the treatment of essential tremor 6, 5

Gastrointestinal Inflammation

  • There is no direct evidence in the provided studies to assist in answering the question about the management of gastrointestinal inflammation in relation to essential tremor.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Managing Essential Tremor.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2020

Research

Management of essential tremor.

Current neurology and neuroscience reports, 2002

Research

Essential tremor: treatment options.

Current treatment options in neurology, 2006

Research

Essential tremor - drug treatments present and future.

Expert review of neurotherapeutics, 2025

Research

Topiramate for essential tremor.

The Cochrane database of systematic reviews, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.